RM1 Project 1 - tAN Naloxone
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT05490134
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Analgesia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Naloxone — DRUGA 0.15 mg/kg bolus dose of naloxone in 10ml normal saline will be administered via an intravenous (IV) line inserted into the antecubital vein of the non-dominant arm.
- Saline — DRUG0.15mg/kg bolus of normal saline in 10ml normal saline will be administered via an intravenous (IV) line inserted into the antecubital vein of the non-dominant arm.
Study Details
This two-visit, randomized, double-blind, sham-controlled trial, uses a novel naloxone blockade model in 136 individuals to determine whether the analgesic effects of a 30-minute transcutaneous auricular neurostimulation (tAN) intervention are mediated through a release of endogenous opioids. Analgesic effects of four various stimulation interventions will be measured (auricular vagus, auricular trigeminal, combination, or sham) while varying the type of intravenous (IV) infusion (either naloxone or saline) a participant is administered to determine whether the analgesic effects are mitigated by pharmacological opioid receptor blockade.
Key Dates
- Start date
- Mar 22, 2023
- Status verified
- Dec 2025
- Primary completion
- Jan 1, 2027
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 136 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: ABVN Only Stimulation30 minutes of ABVN Only stimulation (15Hz stimulation of cymba conchae).
- Experimental: ATN Only Stimulation30 minutes of ATNS Only stimulation (100Hz stimulation adjacently anterior to the tragus)
- Experimental: Combination (ABVN + ATN) Stimulation30 minutes of Combo stimulation (stimulation of both the 15Hz cymba conchae and 100HZ adjacently anterior to the tragus)
- Experimental: Sham Stimulation30 minutes of Sham (15Hz stimulation of the earlobe)
Primary Outcome Measure
Thermal Pain Thresholds [ Time Frame: Change from Baseline Pain Threshold at Post-Stimulation Timepoint ]
Central Contacts
- Bashar Badran, PhD8437926076
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Bashar W Badran, PhD |
Find similar trials in Charleston, SC
Related Studies
- Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain ControlRecruiting · Hawaii Pacific Health · Honolulu, Hawaii
- Conversion of Labor Analgesia for Intrapartum Cesarean Delivery: DPE v CSE v EpiduralEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic PainRecruiting · The University of Texas Medical Branch, Galveston · Galveston, Texas
- Precision Analgesia for Cardiac SurgeryNot Yet Recruiting · Kathirvel Subramaniam · Pittsburgh, Pennsylvania